• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Intellia Therapeutics, Inc. - Common Stock (NQ:NTLA)

12.26 +0.14 (+1.16%)
Delayed Quote Updated: 4:00 PM EDT, Oct 2, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 4,513,955
Open 12.42
Bid (Size) 12.26 (200)
Ask (Size) 12.35 (100)
Prev. Close 12.12
Today's Range 12.10 - 12.77
52wk Range 7.950 - 28.25
Shares Outstanding 88,140,978
Dividend Yield N/A
Chart for  (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
Could This Cathie Wood Stock Soar in 2027? ↗
September 27, 2026
This biotech has grabbed plenty of headlines recently. 
Via The Motley Fool
News headline image
Intellia Eyes Lonvo-z Launch as HAE PDUFA Nears, TTR Study Advances ↗
September 19, 2026
Intellia Therapeutics (NASDAQ:NTLA) executives outlined plans for a potential launch of its hereditary angioedema treatment, lonvo-z, while discussing the company’s ongoing Phase III program in... 
Via MarketBeat
Topics Intellectual Property

Performance

52-Week Range 56.6% below 52-week high
12.26
7.9552W Low 28.2552W High
1 Week 4.0% below 1-week high
11.331W Low 12.771W High

Intellia Therapeutics, Inc. - Common Stock (NTLA) traded between $7.95 and $28.25 over the past 52 weeks and last traded at $12.26, 56.6% below its 52-week high. Over the past week it ranged between $11.33 and $12.77.

Past 12 Months
+4.3%
-3.4%
-30.2%
-6.6%
+33.1%
-34.6%
1W +$0.51
1M -$0.43
3M -$5.30
6M -$0.87
YTD +$3.05
1Y -$6.50

NTLA was -34.6% over the past year, -6.6% over six months, +33.1% year to date, +4.3% in the last week.

12 Months vs Market
NTLA
-34.6%
DIA
+10.1%
SPY
+15.1%
QQQ
+24.3%
IWM
+16.1%

Over the past 12 months NTLA returned -34.6% versus DIA (Dow) +10.1%, SPY (S&P 500) +15.1%, QQQ (Nasdaq 100) +24.3% and IWM (Russell 2000) +16.1%.

Volume & Liquidity 1.13× 3-mo avg
Today 4,513,955 3-mo avg 4.0M
1W
4.8M
1M
4.3M
3M
4.0M
6M
5.2M
YTD
5.1M
1Y
5.6M

NTLA most recently traded 4,513,955 shares against a 3-month average daily volume of 4.0M.

More News

Read More
News headline image
Cathie Wood Goes Bargain Hunting: 3 Stocks She Just Bought ↗
August 31, 2026
Via The Motley Fool
Topics ETFs
Intellia Therapeutics (NASDAQ:NTLA) Slips on Q2 Revenue Miss Despite In-Line Loss ↗
August 06, 2026
Via Chartmill
Intellia Therapeutics Inc (NASDAQ:NTLA) Reports Strong Q4 2025 Revenue Beat and Confirms Key 2026 Pipeline Milestones ↗
February 26, 2026
Via Chartmill
News headline image
Intellia (NTLA) Q2 2026 Earnings Call Transcript ↗
August 13, 2026
Via The Motley Fool
Topics Earnings
News headline image
Intellia Therapeutics Q2 Earnings Call Highlights ↗
August 07, 2026
Via MarketBeat
Topics Earnings Intellectual Property
News headline image
A New CRISPR "DNA Shredder" Could Change Gene-Editing -- What It Means for CRISPR Therapeutics ↗
July 08, 2026
Via The Motley Fool
News headline image
Wall Street Thinks This High-Flying Biotech Stock Can Soar Another 57% ↗
July 01, 2026
Via The Motley Fool
News headline image
Wall Street Expects This Growth Stock That's Already Climbed 70% to Almost Double -- And Here's Why. ↗
June 24, 2026
Via The Motley Fool
News headline image
Intellia Therapeutics vs. Omeros: Which Emerging Biotech Stock Is a Better Buy in 2026? ↗
June 20, 2026
Via The Motley Fool
News headline image
This Stock Is Up 58% This Year. Is It too Late to Buy? ↗
June 17, 2026
Via The Motley Fool
News headline image
1 Sector Warren Buffett and Greg Abel Are Largely Ignoring -- and Why Investors Shouldn't ↗
June 03, 2026
Via The Motley Fool
News headline image
Cathie Wood Goes Bargain Hunting: 3 Stocks She Just Bought ↗
May 06, 2026
Via The Motley Fool
Topics Initial Public Offering
News headline image
3 Biotech Stocks That Could Benefit from the Patent Cliff ↗
April 27, 2026
Via MarketBeat
Topics Intellectual Property
Top movers in Friday's after hours session ↗
April 24, 2026
Via Chartmill
News headline image
2 Healthcare Stocks to Buy and 1 to Approach With Caution ↗
April 15, 2026
Via The Motley Fool
News headline image
This Cathie Wood Stock Is Up 47% This Year: Is It Too Late to Buy? ↗
March 08, 2026
Via The Motley Fool
Topics Death
News headline image
Cathie Wood Goes Bargain Hunting: 3 Stocks She Just Bought ↗
March 03, 2026
Via The Motley Fool
News headline image
Investors Eye Explosive Growth in Anti-Aging Therapies as Market Targets $420B Milestone
March 03, 2026
Via FinancialNewsMedia
News headline image
Why Did NTLA Stock Jump 10% In Pre-Market Today? ↗
March 02, 2026
Via Stocktwits
News headline image
Intellia (NTLA) Q4 2025 Earnings Call Transcript ↗
February 26, 2026
Via The Motley Fool
Topics Earnings
News headline image
This Cathie Wood Stock Is Already Up 41% This Year, But Is It a Buy? ↗
February 07, 2026
Via The Motley Fool
News headline image
NTLA Stock Jumped 13% Today – What Is The Latest FDA Action All About? ↗
January 27, 2026
Via Stocktwits
Nasdaq, S&P 500 Futures Edge Higher Ahead Of Long Weekend: Why NVDA, MU, NTLA, ASTS Are On Traders' Radar Today ↗
January 16, 2026
Via Stocktwits
Topics Stocks

Frequently Asked Questions

Is Intellia Therapeutics, Inc. - Common Stock publicly traded?
Yes, Intellia Therapeutics, Inc. - Common Stock is publicly traded.
What exchange does Intellia Therapeutics, Inc. - Common Stock trade on?
Intellia Therapeutics, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Intellia Therapeutics, Inc. - Common Stock?
The ticker symbol for Intellia Therapeutics, Inc. - Common Stock is NTLA on the Nasdaq Stock Market
What is the current price of Intellia Therapeutics, Inc. - Common Stock?
The current price of Intellia Therapeutics, Inc. - Common Stock is 12.26
When was Intellia Therapeutics, Inc. - Common Stock last traded?
The last trade of Intellia Therapeutics, Inc. - Common Stock was at 10/02/26 04:00 PM ET
What is the market capitalization of Intellia Therapeutics, Inc. - Common Stock?
The market capitalization of Intellia Therapeutics, Inc. - Common Stock is 1.08B
How many shares of Intellia Therapeutics, Inc. - Common Stock are outstanding?
Intellia Therapeutics, Inc. - Common Stock has 1B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap